Influence of Diabetes mellitus on short term mortality in patients with first acute ST

Influence of Diabetes mellitus on short term mortality in patients with first acute ST

This is an automatically generated default intro template – please do not edit.


General information


Title: Influence of Diabetes mellitus on short term mortality in patients with first acute ST
Meta keywords:
Meta description:

Images information


Images path absolute:
Images path relative:
Thumbs path absolute:
Thumbs path relative:

Fields information


Article_Title: Influence of Diabetes mellitus on short term mortality in patients with first acute ST – Elevation myocardial infarction: a ten years retrospective study
Authors: Calin Pop1,2, Lavinia Pop2, Mihaela Roman2, Delia Dan2, Daniela Dicu2
Affiliation: 1 “Vasile Goldis” Western University Arad, Romania
2 Emergency County Hospital Baia Mare, Romania
Abstract: The objective was to compare short-term mortality after a first acute myocardial infarction with ST elevation (STEMI) in patients with and without diabetes mellitus (DM). Between 1.01.2000 – 31.12.2009, 1335 STEMI patients were admitted in the Baia Mare Emergency Hospital: 660 (142 DM) had no thrombolysis, 675 (136 DM) received thrombolysis. In-hospital mortality was 19.4% in the 278 DM patients and 14.3% in the 1057 non-DM patients (p=0.002). Mortality in the subgroups was different: 11.3% in the 539-thrombolysed non-DM patients, 16.5 % in the 136-DM thrombolysed patients (p=0.01) and 21.4% in 142 DM patients without thrombolysis (p<0.0001). DM patients had more failed thrombolysis, 5.8% vs. 2.1%, and more recurrent ischemia, 9.3 % vs. 4.6 %, than non-DM patients had (p=0.002). Short-term mortality after a first STEMI in DM patients is higher due to a worse clinical profile but also to a less effective myocardial reperfusion.
Keywords: mortality, STEMI, diabetes mellitus, thrombolysis, myocardial reperfusion
References: Abaci A., Oguzhan A., Kahraman S. et al., Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239–2242, 1999
Cao J.J., Hudson M., Jankowski M., Whitehouse F., Weaver V.D. Relation of acute and chronic glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am. J. Cardiol. 96:183-186, 2005
Capes S., Hunt D., Malmberg K., et al., Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 335: 773-778, 2000
Gustafsson I., Hildebrandt P., Seibaek M. et al., Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. Eur Heart J. 21: 1937–1943, 2000
Hansen H.-H. T., Joensen A.M., Riahi S. , Malczynski J., Molenberg D. and Ravkilde J., Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. Scandinavian Cardiovascular Journal, Vol. 41, No. 1, 19-24, 2007
Herlitz J., Malmberg K., Karlson B.W., Ryden L., Hjalmarson A., Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med. Scand. 224:31-38, 1998
Koek H.L., Soedamah-Muthu S.S, Kardaun J.W., Gevers E., de Bruin A., Reitsma J.B., Bots M.L, Grobbee D.E., Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J. Epidemiol. 22(12):883-888. Epub 2007
Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang I., Havranek E.P., Krumholz H.M., Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes, Circulations 111: 3078 – 3086, 2005
Kristen F., Robert J. G., Frederick S., Werner K., Andrzej Budaj, David B., Michel M., Philippe G.S., Neelam G., Joel M. G. for the GRACE Investigators, Implications of Diabetes in Patients With Acute Coronary Syndromes. Arch. Intern. Med.164:1457-1463, 2004
Lomuscio A., Castagnone M., Vergani D., et al., Clinical correlation between diabetic and nondiabetic patients with myocardial infarction. Acta Cardiol. 46: 543-554, 1991
Maier B., Thimme W., Kallischnigg G., Graf-Bothe C., Röhnisch J.U., Hegenbarth C., Theres H.; Berlin Myocardial Infarction Registry. Does diabetes mellitus explain the higher hospital mortality of women with acute myocardial infarction? Results from the Berlin Myocardial Infarction Registry. J. Investig. Med. 54(3):143-151, 2006
Malmberg K., Norhammar A., Wedel H., Ryden L., Glycometabolic state at admission: important risk factor of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long term results from the Diabetes and Insulin – Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99: 2626-2632, 1999
Mandelzweig L., Battler A., Boyko V. et al., The second Euro Heart Survey on acute coronary syndrome: characteristics, treatment and outcome of patients with ACS in Europe and Mediterranean Basin in 2004. Eur Heart J. 272: 285-293, 2006
Moreno R., Garcia J., Zamorana J.L., Loupez S., Saunchez H., Acute myocardial infarction in diabetic patients. Are we actually doing bad?, Letters to the Editor. Eur Heart Journal 22, 1359–1362, 2001
Tatu Chitoiu G. (coordonator RO STEMI), Catalina A., Katalin B. et al., Raportul Registrului Român pentru infarctul miocardic acut cu supradenivelare de segment ST (RO-STEMI) (1997-2008). Revista Romana de Cardiologie XXIV, 3, 182-206, 2009
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEJM. 325 (5): 293-302, 1991
Van Belle E., Perie M., Braune D., et al., Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J. Am. Coll. Cardiol., 40: 410-417, 2002
Vant’t Hof A.WJ., Liem A., Suryapranata H., Hoorntje J.C.A., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial brush grade. Circulation 97: 2302–2306, 1998
Zuanetti G., Latini R., Maggioni MD et al., on behalf of GISSI-2 investigators. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J. Am. Coll. Cardiol. 22: 1788–1794, 1993
Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., ICONS Investigators, Is blood glucose an independent predictor of mortality in acute myocardial infarction in thrombolytic era ? J. Am. Coll. Cardiol. 40: 1748-1754, 2002
Wong C.K., White H.D., Dithering over the treatment of diabetics with acute myocardial infarction. Eur Heart J 21: 1907–1909, 2000.
Read_full_article: http://www.jmedar.ro/pdf/vol13/iss4/JMA13-4-10PopC.pdf
Correspondence: Calin Pop, Faculty of Medicine, Vasile Goldis Western University Arad, Str. Unirii nr. 3 Arad 310123 Romania, e-mail:medicbm@yahoo.com

Read full article
Article Title: Influence of Diabetes mellitus on short term mortality in patients with first acute ST – Elevation myocardial infarction: a ten years retrospective study
Authors: Calin Pop1,2, Lavinia Pop2, Mihaela Roman2, Delia Dan2, Daniela Dicu2
Affiliation: 1 “Vasile Goldis” Western University Arad, Romania
2 Emergency County Hospital Baia Mare, Romania
Abstract: The objective was to compare short-term mortality after a first acute myocardial infarction with ST elevation (STEMI) in patients with and without diabetes mellitus (DM). Between 1.01.2000 – 31.12.2009, 1335 STEMI patients were admitted in the Baia Mare Emergency Hospital: 660 (142 DM) had no thrombolysis, 675 (136 DM) received thrombolysis. In-hospital mortality was 19.4% in the 278 DM patients and 14.3% in the 1057 non-DM patients (p=0.002). Mortality in the subgroups was different: 11.3% in the 539-thrombolysed non-DM patients, 16.5 % in the 136-DM thrombolysed patients (p=0.01) and 21.4% in 142 DM patients without thrombolysis (p<0.0001). DM patients had more failed thrombolysis, 5.8% vs. 2.1%, and more recurrent ischemia, 9.3 % vs. 4.6 %, than non-DM patients had (p=0.002). Short-term mortality after a first STEMI in DM patients is higher due to a worse clinical profile but also to a less effective myocardial reperfusion.
Keywords: mortality, STEMI, diabetes mellitus, thrombolysis, myocardial reperfusion
References: Abaci A., Oguzhan A., Kahraman S. et al., Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239–2242, 1999
Cao J.J., Hudson M., Jankowski M., Whitehouse F., Weaver V.D. Relation of acute and chronic glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am. J. Cardiol. 96:183-186, 2005
Capes S., Hunt D., Malmberg K., et al., Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 335: 773-778, 2000
Gustafsson I., Hildebrandt P., Seibaek M. et al., Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. Eur Heart J. 21: 1937–1943, 2000
Hansen H.-H. T., Joensen A.M., Riahi S. , Malczynski J., Molenberg D. and Ravkilde J., Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. Scandinavian Cardiovascular Journal, Vol. 41, No. 1, 19-24, 2007
Herlitz J., Malmberg K., Karlson B.W., Ryden L., Hjalmarson A., Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med. Scand. 224:31-38, 1998
Koek H.L., Soedamah-Muthu S.S, Kardaun J.W., Gevers E., de Bruin A., Reitsma J.B., Bots M.L, Grobbee D.E., Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J. Epidemiol. 22(12):883-888. Epub 2007
Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang I., Havranek E.P., Krumholz H.M., Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes, Circulations 111: 3078 – 3086, 2005
Kristen F., Robert J. G., Frederick S., Werner K., Andrzej Budaj, David B., Michel M., Philippe G.S., Neelam G., Joel M. G. for the GRACE Investigators, Implications of Diabetes in Patients With Acute Coronary Syndromes. Arch. Intern. Med.164:1457-1463, 2004
Lomuscio A., Castagnone M., Vergani D., et al., Clinical correlation between diabetic and nondiabetic patients with myocardial infarction. Acta Cardiol. 46: 543-554, 1991
Maier B., Thimme W., Kallischnigg G., Graf-Bothe C., Röhnisch J.U., Hegenbarth C., Theres H.; Berlin Myocardial Infarction Registry. Does diabetes mellitus explain the higher hospital mortality of women with acute myocardial infarction? Results from the Berlin Myocardial Infarction Registry. J. Investig. Med. 54(3):143-151, 2006
Malmberg K., Norhammar A., Wedel H., Ryden L., Glycometabolic state at admission: important risk factor of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long term results from the Diabetes and Insulin – Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99: 2626-2632, 1999
Mandelzweig L., Battler A., Boyko V. et al., The second Euro Heart Survey on acute coronary syndrome: characteristics, treatment and outcome of patients with ACS in Europe and Mediterranean Basin in 2004. Eur Heart J. 272: 285-293, 2006
Moreno R., Garcia J., Zamorana J.L., Loupez S., Saunchez H., Acute myocardial infarction in diabetic patients. Are we actually doing bad?, Letters to the Editor. Eur Heart Journal 22, 1359–1362, 2001
Tatu Chitoiu G. (coordonator RO STEMI), Catalina A., Katalin B. et al., Raportul Registrului Român pentru infarctul miocardic acut cu supradenivelare de segment ST (RO-STEMI) (1997-2008). Revista Romana de Cardiologie XXIV, 3, 182-206, 2009
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEJM. 325 (5): 293-302, 1991
Van Belle E., Perie M., Braune D., et al., Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J. Am. Coll. Cardiol., 40: 410-417, 2002
Vant’t Hof A.WJ., Liem A., Suryapranata H., Hoorntje J.C.A., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial brush grade. Circulation 97: 2302–2306, 1998
Zuanetti G., Latini R., Maggioni MD et al., on behalf of GISSI-2 investigators. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J. Am. Coll. Cardiol. 22: 1788–1794, 1993
Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., ICONS Investigators, Is blood glucose an independent predictor of mortality in acute myocardial infarction in thrombolytic era ? J. Am. Coll. Cardiol. 40: 1748-1754, 2002
Wong C.K., White H.D., Dithering over the treatment of diabetics with acute myocardial infarction. Eur Heart J 21: 1907–1909, 2000.
*Correspondence: Calin Pop, Faculty of Medicine, Vasile Goldis Western University Arad, Str. Unirii nr. 3 Arad 310123 Romania, e-mail:medicbm@yahoo.com